The potential for life-changing biomedical advances has never been greater, but the funding environment has never been more challenging. See what the University of Chicago Biological Sciences Division is doing to empower researchers for success in this new landscape. [Read more]
Of all the possible experiments available in biomedical research, only a small subset are ever tackled by scientists. This is in part due to institutional and cultural pressures that lead researchers to avoid risk-taking and choose inefficient research strategies, according to a new study based on a computational analysis of millions of patents and research articles. ScienceLife spoke with co-author Andrey Rzhetsky about the proposed steps for a more productive future. [Read more]
A new computational method developed by a team led by Andrey Rzhetsky, PhD, measures disparities between resources dedicated to a disease and its relative burden on society, providing an unbiased, data-driven framework to help scientific and political communities assess resource investment and identify unmet medical needs. [Read more]
Scientists, public health experts, economists and activists gathered at a recent conference hosted by Microsoft to talk about how technology can help contain the next Ebola outbreak. [Read more]
University of Chicago researchers receive new supplemental awards to counter gender bias in NIH-funded research.
Investment sets the stage for a transformative shift in science.
[Read more]
Biology used to be the scientific discipline where data was at a premium, a rare resource painstakingly collected in the field or the laboratory. But today’s biologists are confronted with a flood of data, a fire-hose torrent of genetic and [Read more]
The public perception of science in action typically involves a person in a white coat pouring brightly-colored fluids in and out of test tubes. Sure, a little bit of that does go on in a laboratory. But before the glassware is broken out, a lot of [Read more]